4.7 Article

Intrathymic transplantation of bone marrow-derived progenitors provides long-term thymopoiesis

Journal

BLOOD
Volume 115, Issue 10, Pages 1913-1920

Publisher

AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2009-06-229724

Keywords

-

Categories

Funding

  1. National Institute of Allergy and Infectious Diseases [R01AI059349]
  2. Association Francaise contre les Myopathies
  3. European Community [LSHC-CT-2005-018914]
  4. Portuguese Foundation for Science and Technology [SFRH/BD/235 53/2005]
  5. Inserm
  6. Centre National de la Recherche Scientifique (CNRS)
  7. French Ministry of Health and ATTACK

Ask authors/readers for more resources

The sustained differentiation of T cells in the thymus cannot be maintained by resident intrathymic (IT) precursors and requires that progenitors be replenished from the bone marrow (BM). In patients with severe combined immunodeficiency (SCID) treated by hematopoietic stem cell transplantation, late T-cell differentiation defects are thought to be due to an insufficient entry of donor BM progenitors into the thymus. Indeed, we find that the intravenous injection of BM progenitors into non-conditioned zeta-chain-associated protein kinase 70 (ZAP-70)-deficient mice with SCID supports short-but not long-term thymopoiesis. Remarkably, we now show that the IT administration of these progenitors produces a significant level of donor-derived thymopoiesis for more than 6 months after transplantation. In contrast to physiologic thymopoiesis, long-term donor thymopoiesis was not due to the continued recruitment of progenitors from the BM. Rather, IT transplantation resulted in the unique generation of a large population of early c-Kithigh donor precursors within the thymus. These ZAP-70-deficient mice that received an IT transplant had a significantly increased prothymocyte niche compared with their untreated counterparts; this phenotype was associated with the generation of a medulla. Thus, IT administration of BM progenitors results in the filling of an expanded precursor niche and may represent a strategy for enhancing T-cell differentiation in patients with SCID. (Blood. 2010; 115: 1913-1920)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available